We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Colin Kellaher U.S.-listed shares of Kazia Therapeutics jumped in premarket trading Thursday after the Australian biotechnology company said the U.S. Food and Drug Administration granted a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | -0.012 | -13.0434782609 | 0.092 | 0.11 | 0.051 | 924417 | 0.07803279 | DE |
52 | -0.115 | -58.9743589744 | 0.195 | 0.24 | 0.051 | 267695 | 0.11251045 | DE |
156 | -1.455 | -94.7882736156 | 1.535 | 1.65 | 0.051 | 169602 | 0.37271314 | DE |
260 | -0.34 | -80.9523809524 | 0.42 | 1.88 | 0.051 | 189319 | 0.63770969 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions